Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,178.00    -4.00 (-0.18%)
Bid:
2,192.00
Ask:
2,220.00
Spread: 28.00 (1.277%)
Market Cap: £1.45b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Board Change

13 Mar 2007 07:02

Genus PLC13 March 2007 FOR IMMEDIATE RELEASE 13 March 2007 Genus plc ("Genus" or "the Company") Board Change Genus, the world's leading animal genetics company, announces that Martin Bodenwill be joining the Board as Finance Director with effect from 2nd April 2007. David Timmins, the current Finance Director, will be leaving the Company after ashort transitional period to pursue other opportunities. Mr Timmins, who joinedthe Board in March 2004, has played an important role in the development of theCompany, in particular the reverse takeover and the integration to date of SygenInternational plc ("Sygen"). He has also led the process of adoptingInternational Financial Reporting Standards in the Interim Results for the sixmonths ended 31st December 2006, one year in advance of the requirement for AIMlisted companies, in preparation for the move to the Main Market later thisyear. Mr Timmins has reached the decision that it is time for him to move ontonew challenges. The Board would like to thank Mr Timmins for his contribution to the success ofthe Company. Mr Boden, aged 48, is a Chartered Accountant with considerable experience oflarge and diverse FTSE100 companies, most recently being Group FinancialController of GUS plc, a FTSE100 retail and business services company. The Boardbelieves Mr Boden's abilities and experience will greatly benefit the Companyparticularly given the Company's forthcoming move to the Official List. Genus plc is also pleased to announce that Richard Wood, Chief Executive, is to continue with the Company until 31st March 2009 to lead the Company through its next stage of development, to include its intended move to the Official List and the delivery of the remaining synergies to be achieved from the Sygen acquisition. For further information, please contact: Genus PlcJohn Hawkins, Chairman Tel: 01189 450128Richard Wood, Chief Executive Tel: 01256 345971 Buchanan CommunicationsCharles Ryland/Suzanne Brocks Tel: 020 7466 5000 The following is disclosed in respect of Mr Boden in accordance with Schedule 2paragraph (g) of the AIM Rules: Current Directorships Directorships in the last 5 years Brigstock Finance Limited Argos Holdings Limited Experian (UK) Holdings Limited Stanhope Finance Limited There are no other matters requiring disclosure under Schedule 2 paragraph (g)of the AIM rules. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 20269:20 amRNSTotal Voting Rights
13th Apr 20265:59 pmRNSDirector/PDMR Shareholding
1st Apr 20269:40 amRNSDirector/PDMR Shareholding
10th Mar 20263:56 pmRNSNotification of Major Holdings
10th Mar 20263:56 pmRNSNotification of Major Holdings
4th Mar 202610:33 amRNSDirector/PDMR Shareholding
4th Mar 202610:08 amRNSDirector Declaration
27th Feb 202612:48 pmRNSDirector/PDMR Shareholding
26th Feb 20267:00 amRNSInterim Results
2nd Feb 202612:39 pmRNSBlock Listing Return
2nd Feb 202611:21 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSSuccessful formation of Chinese porcine JV
23rd Jan 20265:23 pmRNSPRP Regulatory Progress – Canada
16th Jan 20267:00 amRNSHalf Year Trading Update – Ahead of expectations
27th Nov 20257:00 amRNSDirector/PDMR Shareholding
19th Nov 202512:12 pmRNSResults of AGM
19th Nov 20257:00 amRNSNon-Executive Director Appointments
19th Nov 20257:00 amRNSAGM Trading Update
3rd Nov 202510:56 amRNSTotal Voting Rights
14th Oct 20254:02 pmRNSNotification of Major Holdings
10th Oct 20257:00 amRNSNotice of AGM
1st Oct 20259:47 amRNSTotal Voting Rights
25th Sep 20254:49 pmRNSDirector/PDMR Shareholding
24th Sep 202511:35 amRNSDirector/PDMR Shareholding
19th Sep 20252:39 pmRNSDirector/PDMR Shareholding
17th Sep 202512:14 pmRNSDirector/PDMR Shareholding
11th Sep 202512:20 pmRNSDirector/PDMR Shareholding
8th Sep 20254:05 pmRNSAdditional Listing
4th Sep 20257:00 amRNSPreliminary results
4th Sep 20257:00 amRNSAccelerated Chinese porcine JV formation
28th Aug 20254:57 pmRNSNotification of Major Holdings
19th Aug 20253:03 pmRNSNotification of Major Holdings
19th Aug 20257:00 amRNSNotification of Major Holdings
6th Aug 202510:51 amBUSHolding(s) in Company
4th Aug 202511:14 amRNSNotification of Major Holdings
1st Aug 202510:10 amRNSBlock Listing Six Monthly Return
1st Aug 202510:05 amRNSTotal Voting Rights
15th Jul 20257:00 amRNSFY25 Trading Update
9th May 20259:25 amRNSAppointment of Financial Adviser & joint Broker
1st May 20252:28 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSPRRS Resistant Pig – FDA Approval
25th Apr 20254:30 pmRNSNotification of Major Holdings
25th Apr 20254:28 pmRNSNotification of Major Holdings
2nd Apr 20255:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20253:43 pmRNSNotification of Major Holdings
13th Mar 20257:00 amRNSAppointment of Chief Financial Officer Designate
3rd Mar 202511:32 amRNSTotal Voting Rights
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.